Market Cap 286.73M
Revenue (ttm) 57.56M
Net Income (ttm) -44.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -76.69%
Debt to Equity Ratio -0.54
Volume 1,367,400
Avg Vol 1,640,256
Day's Range N/A - N/A
Shares Out 98.87M
Stochastic %K 22%
Beta 2.76
Analysts Strong Sell
Price Target $9.97

Latest News on AQST

Aquestive Therapeutics: Five Foci For 2025

Jan 6, 2025, 12:13 AM EST - 3 months ago

Aquestive Therapeutics: Five Foci For 2025


Aquestive: Rare Opportunity With Dual Platform Strategy

Nov 5, 2024, 2:09 PM EST - 5 months ago

Aquestive: Rare Opportunity With Dual Platform Strategy


Aquestive Therapeutics: Bullish Roadmap After Q2 Earnings

Aug 22, 2024, 11:37 PM EDT - 7 months ago

Aquestive Therapeutics: Bullish Roadmap After Q2 Earnings


Aquestive Therapeutics Provides Business Update

Oct 9, 2023, 8:00 AM EDT - 1 year ago

Aquestive Therapeutics Provides Business Update